Drug Dictionary


Erleada® (08-3-2018)

Class: Hormonal therapy Generic Name: Apalutamide Trade Name: Erleada® How is this drug used? Erleada is used for the treatment of patients with castration-resistant prostate cancer that has not metastasized. What is the mechanism of action? Erleada... Continue Reading

Apalutamide (08-3-2018)

Class: Hormonal therapy Generic Name: Apalutamide Trade Name: Erleada® How is this drug used? Erleada is used for the treatment of patients with castration-resistant prostate cancer that has not metastasized. What is the mechanism of action? Erleada... Continue Reading

Xtandi® (08-3-2018)

Class: Hormonal therapy Generic Name: Enzalutamide Trade Name: Xtandi® How is this drug used? Xtandi is used for the treatment of castration-resistant prostate cancer. What is the mechanism of action? Xtandi interferes with the ability of male hormones... Continue Reading

Enzalutamide (08-3-2018)

Class: Hormonal therapy Generic Name: Enzalutamide Trade Name: Xtandi® How is this drug used? Xtandi is used for the treatment of castration-resistant prostate cancer. What is the mechanism of action? Xtandi interferes with the ability of male hormones... Continue Reading

Venclexta® (08-3-2018)

Class: Biological Therapy Generic Name: Venetoclax Trade Name: Venclexta® How is this drug used? Venclexta is approved for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a specific chromosomal... Continue Reading

Venetoclax (08-3-2018)

Class: Biological Therapy Generic Name: Venetoclax Trade Name: Venclexta® How is this drug used? Venclexta is approved for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a specific chromosomal... Continue Reading

Enorafenib (08-3-2018)

Class: Biological Therapy Generic Name: Enorafenib Trade Name: Braftovi For which conditions is this drug approved? BRAFTOVI is approved in combination with Mektovi® (binimetinib) for the treatment of melanoma with a BRAF V600E or V600K mutation [as... Continue Reading

Braftovi (08-3-2018)

Class: Biological Therapy Generic Name: Enorafenib Trade Name: Braftovi For which conditions is this drug approved? BRAFTOVI is approved in combination with Mektovi® (binimetinib) for the treatment of melanoma with a BRAF V600E or V600K mutation [as... Continue Reading

mFOLFIRINOX Found Superior to Gemzar for Treatment Surgically Resected Pancreatic Cancer (06-19-2018)

The results of a recently presented clinical study at the American Society of Clinical Oncology meetings last week suggest that more aggressive chemotherapy treatment improves outcomes compared to single agent Gemzar (gemcitabine) chemotherapy which has... Continue Reading

abemaciclib (01-17-2018)

Generic Name: abemaciclib Trade Name: Verzenio For which conditions is this drug approved? Verzenio is indicated for use: In combination with fulvestrant in women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer... Continue Reading

Next Page »